Moderna, Inc. (MRNA)
Data as of Nov 3, 9:50 AM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
MRNA key stats
MRNA GlowScore: Active
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Moderna, Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
What's moving MRNA today
Updated November 3, 2026As of November 3, 2026, Moderna, Inc. (MRNA) stock climbed to $229.39, up 3.88% (+$8.56) versus the previous close. On the day, shares have traded between $220.23 and $233.32. That puts MRNA in the upper third of its 52-week range of $22.28 to $254.48. Moderna, Inc. operates in the biological products, (no diagnostic substances) space and carries a market capitalization of roughly $88.16 billion, with about 1.61 million shares changing hands.
Latest MRNA news
- Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second ActYahoo Finance· Nov 3, 8:55 AM ET
- What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Oct. 30Yahoo Finance· Nov 3, 6:05 AM ETRSP
- Could Investing in Moderna's Stock Double Your Money?fool.com· Nov 3, 5:28 AM ET
- Earnings live updates: Roku posts earnings beat ahead of acquisition by FoxYahoo Finance· Nov 2, 4:28 PM ET
- What Is Moderna (MRNA) Answering As FDA Vaccine Betting Markets Grow?Yahoo Finance· Nov 2, 2:09 PM ET
- Amgen Just Gave Its Shareholders Great Newsfool.com· Nov 2, 12:45 PM ET
- Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?Yahoo Finance· Nov 2, 11:22 AM ET
- Buy Moderna Stock Before Q3 Earnings? Here's What to KnowYahoo Finance· Nov 2, 11:14 AM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want MRNA headlines, alerts and AI research in one place? Create a free account →
MRNA buzz on Stocktwits
117,669 watchers$SLS $MRNA Per the SAP approved by the Fda November 2022, ALL GPS NEEDS IS ≤ .636 and its worth $40B to Big Pharma.
@55X_ROI_Q1_2026· Nov 3, 9:50 AM ET
$MRNA who thinks it is a dead cat bounce?
@TradesWithTom· Nov 3, 9:48 AM ET
$MRNA getting very juicy for a short again. Short naked calls for now for 300+
@LongerThanLong· Nov 3, 9:47 AM ET· Bearish
$MRNA The Fall is coming….
@BullTMC· Nov 3, 9:46 AM ET· Bearish
$INO $MRNA $RVMD $SLS As of 2026-11-03 09:25:23 AM EST, there were 4,000 shares available with a fee of 5.69%. Warrants are almost Extinguished going in to one ☝️ of the biggest Oncology readouts in a Millenia. ✌️🙏❤️🩹
@SellasgpsCurativeBAT11· Nov 3, 9:44 AM ET· Bullish
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
MRNA Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on MRNA
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.